Broncus Completes the First Case of Registered Clinical Trials of Its Targeted Lung Denervation Radiofrequency Ablation System

Broncus Holding Corporation has completed the first case of registered clinical trials of its targeted lung denervation radiofrequency ablation system.

Scroll to Top